REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/28/2026
Back to search
Official data from USPTO
DONGCHENG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
03/01/2026
Trademark type
Combined
Nice classes
5
Filing date
02/17/2016
Registration date
02/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2023
Last transaction
03/01/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/10/2014
First use in commerce
10/10/2014
Drawing code
3
Owner type
99
Owner location
SHANDONG PROVINCE, CN
Examiner
MURRAY, GEORGE WILLIAM
Law office
N30
Current location
TMO LAW OFFICE 121
Mark description
The mark consists of an incomplete circular design to the left of two Chinese characters and the stylized words "DONGCHENG".
Holders and representatives
Holders
YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Representatives
Henry G. Chow
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological herbicides; Capsules sold empty for pharmaceuticals; Cardiovascular pharmaceuticals; Chemical reagents for medical or veterinary purposes; Chondroitin preparations; Dietary supplements for human consumption; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparationsdantrolene sodium for injection; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of joint disease ; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Tumor suppressing agents; Vitamin preparations
Publications
History of USPTO decisions and trademark events.
24 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/06/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/06/2023
ES8R
TEAS SECTION 8 RECEIVED
10/11/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/28/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/28/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/24/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/23/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/18/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/12/2017
IUAF
USE AMENDMENT FILED
12/16/2016
EISU
TEAS STATEMENT OF USE RECEIVED
12/16/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2016
PUBO
PUBLISHED FOR OPPOSITION
07/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2016
DOCK
ASSIGNED TO EXAMINER
06/02/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/25/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2016
NWAP
NEW APPLICATION ENTERED
02/20/2016
Continuous trademark protection
Get notified about every new filing that threatens DONGCHENG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.